Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.
Burchard PR, Ruffolo LI, Ullman NA, Dale BS, Dave YA, Hilty BK, Ye J, Georger M, Jewell R, Miller C, De Las Casas L, Jarolimek W, Perryman L, Byrne MM, Loria A, Marin C, Chávez Villa M, Yeh JJ, Belt BA, Linehan DC, Hernandez-Alejandro R.
Burchard PR, et al. Among authors: dale bs.
Hepatol Commun. 2024 Aug 5;8(8):e0502. doi: 10.1097/HC9.0000000000000502. eCollection 2024 Aug 1.
Hepatol Commun. 2024.
PMID: 39101793
Free PMC article.